WO2007009790A1 - Cosmetic compositions containing hyaluronic acid and colostrum - Google Patents

Cosmetic compositions containing hyaluronic acid and colostrum Download PDF

Info

Publication number
WO2007009790A1
WO2007009790A1 PCT/EP2006/007152 EP2006007152W WO2007009790A1 WO 2007009790 A1 WO2007009790 A1 WO 2007009790A1 EP 2006007152 W EP2006007152 W EP 2006007152W WO 2007009790 A1 WO2007009790 A1 WO 2007009790A1
Authority
WO
WIPO (PCT)
Prior art keywords
colostrum
hyaluronic acid
compositions
cosmetic compositions
skin
Prior art date
Application number
PCT/EP2006/007152
Other languages
French (fr)
Inventor
Rosa Maria Gobbi
Original Assignee
Bionest Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionest Ltd. filed Critical Bionest Ltd.
Publication of WO2007009790A1 publication Critical patent/WO2007009790A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter

Definitions

  • This invention relates to cosmetic compositions containing hyaluronic acid, colostrum, sericin, resveratrol and tocopherols.
  • This invention therefore relates to cosmetic compositions based on hyaluronic acid and colostrum for the treatment of older skin.
  • this invention relates to cosmetic compositions containing hyaluronic acid or its salts, mammalian colostrum, sericin, resveratrol and tocopherols.
  • the cosmetic compositions according to the invention contain hyaluronic acid sodium salt.
  • the cosmetic compositions according to the invention contain bovine or equine colostrum.
  • the content of hyaluronic acid or its salts in the compositions according to the invention will range between 0.1 and 5%, and preferably between 0.5 and 1%, and the colostrum content will range between 5 and 30%, and preferably between 10 and 20%.
  • Sericin is typically present in percentages of between 0.1 and 2% in weight, and preferably between 0.2 and 1%, while resveratrol is present in percentages of between 0.001 and 0.1%.
  • compositions according to the invention can also contain unsaponifiable fractions of vegetable oils, especially unsaponifiable fractions of Olea europaea (olive) oil.
  • compositions according to the invention are greater than that obtained following separate administration of the individual constituents of the combination. This superior effect appears to be due to synergy between hyaluronic acid and colostrum, which produces unexpected results in terms of the elasticity, texture, tone, resistance, moisturising and glow of the facial skin.
  • association according to the invention - prevents and reduces sagging of the skin; improves the tone and elasticity of the skin; - exerts an immediate, long-lasting face-lift effect; performs a long-lasting moisturising and antioxidant action; strongly firms and remodels the contours and features of the face.
  • compositions according to the invention are suitable for all types of skin.
  • compositions will be applied with a gentle massage to the perfectly clean face and neck.
  • the frequency of use will be several times a day.
  • the facial skin appears better toned, more elastic, relaxed and firm, and the contours look relaxed and firmer, more compact and better delineated. Wrinkles are attenuated in terms of both number and depth. The skin glows, and is fresh, soft and revitalised. Liver spots are attenuated.
  • compositions according to the invention could be formulated according to conventional methods well known in cosmetic technology, using excipients, diluents, filling agents and anti-caking agents acceptable for their final use, in particular conventional preservatives such as parabens, potassium sorbate, dihydroacetic sodium, imidazolidinyl urea, etc.
  • formulations according to the invention are hydrogel masks, fluid gels, creams, lotions, etc.

Abstract

This invention relates to cosmetic compositions based on hyaluronic acid and colostrum for the treatment of older skin. These compositions produce unexpected results in terms of the elasticity, texture, tone, resistance, moisturising and glow of the facial skin.

Description

COSMETIC COMPOSITIONS CONTAINING HYALURONIC ACID AND COLOSTRUM
FIELD OF INVENTION
This invention relates to cosmetic compositions containing hyaluronic acid, colostrum, sericin, resveratrol and tocopherols.
PRIOR ART One of the consequences of skin aging is dehydration and a deterioration in the tone, elasticity and texture of the tissues.
The consequences are clearly visible: the contours of the face become heavier and ill-defined, the area between the cheekbones and the chin becomes heavy, and the skin looks tired, toneless, dry and dehydrated. The cosmetic industry offers countless products for the treatment of older skin such as day and night creams, gel masks and moisturising fluids, firming products, products with a face-lift effect, and so on. However, the results do not always correspond to expectations. DESCRIPTION OF THE INVENTION It has now been discovered that the combination of hyaluronic acid and colostrum is particularly effective in the treatment of older skin.
This invention therefore relates to cosmetic compositions based on hyaluronic acid and colostrum for the treatment of older skin.
More particularly, this invention relates to cosmetic compositions containing hyaluronic acid or its salts, mammalian colostrum, sericin, resveratrol and tocopherols.
According to a preferred aspect, the cosmetic compositions according to the invention contain hyaluronic acid sodium salt.
According to a preferred aspect, the cosmetic compositions according to the invention contain bovine or equine colostrum. The content of hyaluronic acid or its salts in the compositions according to the invention will range between 0.1 and 5%, and preferably between 0.5 and 1%, and the colostrum content will range between 5 and 30%, and preferably between 10 and 20%. Sericin is typically present in percentages of between 0.1 and 2% in weight, and preferably between 0.2 and 1%, while resveratrol is present in percentages of between 0.001 and 0.1%.
Examples of tocopherols include tocopherol esters or vitamin E, in percentages of between 0.1 and 2%. The compositions according to the invention can also contain unsaponifiable fractions of vegetable oils, especially unsaponifiable fractions of Olea europaea (olive) oil.
The effect of the compositions according to the invention is greater than that obtained following separate administration of the individual constituents of the combination. This superior effect appears to be due to synergy between hyaluronic acid and colostrum, which produces unexpected results in terms of the elasticity, texture, tone, resistance, moisturising and glow of the facial skin.
More particularly, the association according to the invention: - prevents and reduces sagging of the skin; improves the tone and elasticity of the skin; - exerts an immediate, long-lasting face-lift effect; performs a long-lasting moisturising and antioxidant action; strongly firms and remodels the contours and features of the face. USE
The compositions according to the invention are suitable for all types of skin.
The compositions will be applied with a gentle massage to the perfectly clean face and neck. The frequency of use will be several times a day.
RESULTS
Even after the first few applications, the facial skin appears better toned, more elastic, relaxed and firm, and the contours look relaxed and firmer, more compact and better delineated. Wrinkles are attenuated in terms of both number and depth. The skin glows, and is fresh, soft and revitalised. Liver spots are attenuated.
The compositions according to the invention could be formulated according to conventional methods well known in cosmetic technology, using excipients, diluents, filling agents and anti-caking agents acceptable for their final use, in particular conventional preservatives such as parabens, potassium sorbate, dihydroacetic sodium, imidazolidinyl urea, etc.
Preferred examples of formulations according to the invention are hydrogel masks, fluid gels, creams, lotions, etc.
The following are some examples of formulations according to the invention.
EXAMPLE 1 - Hydrogel formulation
Figure imgf000004_0001
EXAMPLE 2 - Serum
Figure imgf000005_0001

Claims

1. Cosmetic compositions containing hyaluronic acid or its salts, mammalian colostrum, sericin, tocopherols and resveratrol.
2. Compositions as claimed in claim 1 , containing hyaluronic acid sodium salt.
3. Compositions as claimed in claim 1 , containing bovine or equine colostrum.
4. Compositions as claimed in claims 1 - 3, wherein the content of hyaluronic acid or its salts ranges between 0.1 and 5%, and the colostrum content ranges between 5 and 30%.
5. Compositions as claimed in claims 1 - 4, wherein the content of hyaluronic acid or its salts ranges between 0.1 and 5%, and the colostrum content ranges between 10 and 20%.
6. Compositions as claimed in one of claims 1 to 5, also containing unsaponifiable fractions of olive oil.
7. Use of hyaluronic acid or its salts and mammalian colostrum to prepare cosmetic compositions for the treatment of older skin.
PCT/EP2006/007152 2005-07-22 2006-07-20 Cosmetic compositions containing hyaluronic acid and colostrum WO2007009790A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2005A001416 2005-07-22
ITMI20051416 ITMI20051416A1 (en) 2005-07-22 2005-07-22 COSMETIC COMPOSITIONS CONTAINING HYALURONIC ACID AND COLOSTRO

Publications (1)

Publication Number Publication Date
WO2007009790A1 true WO2007009790A1 (en) 2007-01-25

Family

ID=37025323

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/007152 WO2007009790A1 (en) 2005-07-22 2006-07-20 Cosmetic compositions containing hyaluronic acid and colostrum

Country Status (2)

Country Link
IT (1) ITMI20051416A1 (en)
WO (1) WO2007009790A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028652A1 (en) 2008-09-12 2010-03-18 Nanoko A/S Colostrum composition
ITPD20090015A1 (en) * 2009-01-26 2010-07-27 Sitar S R L PREPARATION FOR THE TREATMENT AND PREVENTION OF THE RAGADI AND PREVENTION OF THE STRETCH MARKS AT THE TOPIC LEVEL
WO2011018501A3 (en) * 2009-08-12 2011-10-20 Laboratoires Expanscience Composition including an unsaponifiable fraction
CN102239922A (en) * 2010-05-13 2011-11-16 江苏星驰生物科技有限公司 Colostrum formula powder
WO2012116391A1 (en) * 2011-02-09 2012-09-07 Lien Wendy Cosmetic or pharmaceutical formulation
ITMI20112438A1 (en) * 2011-12-30 2013-07-01 Bionest Ltd INJECTABLE FORMULATIONS OF CYTOKINES, GROWTH FACTORS, CHEMOTACTIC FACTORS, STAMINAL STIMULATION FATORS AND RNA FOR DERMA REGENERATION
WO2016193791A1 (en) * 2015-06-05 2016-12-08 Caudalie Ip Limited Process for stimulating hyaluronic acid synthesis
FR3036956A1 (en) * 2015-06-05 2016-12-09 Caudalie Ip Ltd METHOD FOR STIMULATING THE SYNTHESIS OF HYALURONIC ACID

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714605A1 (en) * 1994-01-05 1995-07-07 Schlee Serge Compsn. contg. colostrum, mimosa tenuiflora extract and rose water
US5750149A (en) * 1993-01-26 1998-05-12 Horse Vitality Ltd Pharmaceutical and dermocosmetic compositions containing equine colostrum
WO1999004747A2 (en) * 1997-07-25 1999-02-04 Unilever Plc Cosmetic compositions
FR2815253A1 (en) * 2000-10-12 2002-04-19 Isabelle Laurence Zichi Composition for cosmetic or dermatological use, with the aim of reduction of dryness of skin and ageing symptoms, comprises at least one glycosamino glycan, at least one polyol or polyol ether and at least one hydroxyacid
KR100494229B1 (en) * 2003-03-24 2005-06-13 김정호 manufacturing process of sericin and sericin mask pack

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750149A (en) * 1993-01-26 1998-05-12 Horse Vitality Ltd Pharmaceutical and dermocosmetic compositions containing equine colostrum
FR2714605A1 (en) * 1994-01-05 1995-07-07 Schlee Serge Compsn. contg. colostrum, mimosa tenuiflora extract and rose water
WO1999004747A2 (en) * 1997-07-25 1999-02-04 Unilever Plc Cosmetic compositions
FR2815253A1 (en) * 2000-10-12 2002-04-19 Isabelle Laurence Zichi Composition for cosmetic or dermatological use, with the aim of reduction of dryness of skin and ageing symptoms, comprises at least one glycosamino glycan, at least one polyol or polyol ether and at least one hydroxyacid
KR100494229B1 (en) * 2003-03-24 2005-06-13 김정호 manufacturing process of sericin and sericin mask pack

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Natural Health Care Products from Long Natural Health", XP002403756, Retrieved from the Internet <URL:www.longnaturalhealth.com/products.asp?P=154> [retrieved on 20060919] *
DATABASE PROMT STN; 1991, "FDC Reports Rose Sheet", XP002403759 *
DATABASE WPI Week 200512, Derwent World Patents Index; AN 2005-108741, XP002407255 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028652A1 (en) 2008-09-12 2010-03-18 Nanoko A/S Colostrum composition
US8637075B2 (en) 2008-09-12 2014-01-28 Pharma Gp Aps Colostrum composition
ITPD20090015A1 (en) * 2009-01-26 2010-07-27 Sitar S R L PREPARATION FOR THE TREATMENT AND PREVENTION OF THE RAGADI AND PREVENTION OF THE STRETCH MARKS AT THE TOPIC LEVEL
WO2011018501A3 (en) * 2009-08-12 2011-10-20 Laboratoires Expanscience Composition including an unsaponifiable fraction
US9282759B2 (en) 2009-08-12 2016-03-15 Laboratoires Expanscience Composition including an unsaponifiable fraction
CN102239922A (en) * 2010-05-13 2011-11-16 江苏星驰生物科技有限公司 Colostrum formula powder
GB2502029A (en) * 2011-02-09 2013-11-13 Wendy Lien Cosmetic or pharmaceutical formulation
WO2012116391A1 (en) * 2011-02-09 2012-09-07 Lien Wendy Cosmetic or pharmaceutical formulation
GB2502029B (en) * 2011-02-09 2018-02-21 Forward Scout Entpr Pty Ltd Cosmetic or pharmaceutical formulation comprising hyaluronate crosspolymer and one or more of; azelaic acid, or derivative, and natural oils
US9931289B2 (en) 2011-02-09 2018-04-03 Forward Scout Enterprises Pty Ltd Cosmetic or pharmaceutical formulation
ITMI20112438A1 (en) * 2011-12-30 2013-07-01 Bionest Ltd INJECTABLE FORMULATIONS OF CYTOKINES, GROWTH FACTORS, CHEMOTACTIC FACTORS, STAMINAL STIMULATION FATORS AND RNA FOR DERMA REGENERATION
WO2016193791A1 (en) * 2015-06-05 2016-12-08 Caudalie Ip Limited Process for stimulating hyaluronic acid synthesis
FR3036956A1 (en) * 2015-06-05 2016-12-09 Caudalie Ip Ltd METHOD FOR STIMULATING THE SYNTHESIS OF HYALURONIC ACID
US10470987B2 (en) 2015-06-05 2019-11-12 Tomcat International Limited Process for stimulating hyaluronic acid synthesis

Also Published As

Publication number Publication date
ITMI20051416A1 (en) 2007-01-23

Similar Documents

Publication Publication Date Title
WO2007009790A1 (en) Cosmetic compositions containing hyaluronic acid and colostrum
US10016347B2 (en) Hair-conditioning mask
EP3436043B1 (en) Compositions containing plant mucilage
CN109998972A (en) A kind of foaming abundancy face washing mud and preparation method thereof
JP5784910B2 (en) Cosmetic composition containing glycogen for skin application having gloss effect
JP6881006B2 (en) Cosmetics
KR101723845B1 (en) Natural cosmetic composition of mask pack and method for manufacturing natural cosmetic composition of mask pack
WO2020059283A1 (en) Cuticle remover, method for producing same, use thereof
EP2859882A1 (en) Natural skin care composition
CN106902004A (en) Preservative free preserving moisture and protecting skin emulsion formulations
JP4374362B2 (en) Pack salt and pack agent using the same
RU2006124239A (en) COMPOSITIONS FOR USE ON SKIN
KR102129355B1 (en) Composition for pack
JP2019043918A (en) Cosmetic method
JP2014024825A (en) Body-care agent
CN106265286A (en) A kind of cosmetic composition containing black Fructus Lycii extract and eye cream
US8268364B1 (en) Water based pain relieving composition
WO2004022024A1 (en) Compositions comprising soy products and organic salts of certain metals
US20040037900A1 (en) Shaving gel formulation and methods of use
KR101891333B1 (en) Cosmetic composition for removing demodex and method of preparing the same
KR20210031078A (en) Cream type Cosmetic Composition for Cleansing comprising High content of Oil phase and Preparation Method thereof
JP2009221127A (en) Cosmetic
JP2006248940A (en) Cosmetic for skin or hair
JP5350434B2 (en) Basic lotion
US20050226837A1 (en) Oily cosmetic composition having a suspensory capacity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06776317

Country of ref document: EP

Kind code of ref document: A1